The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...

UroGen was up nearly 52% when markets closed on Thursday. Zusduri is the company’s second commercial product, following the low-grade upper tract urothelial cancer drug Jelmyto, which was approved in ...

This week, the album at No. 1 on the charts is one everyone saw coming: With the biggest streaming numbers of 2025 and strong sales to boot, Morgan Wallen's I'm the Problem is the chart-topper it ...

For those able to read price charts competently, the market itself, through price action contained in the chart, will reveal what it's doing and, to some degree, where it's headed.

Use a blood pressure chart to interpret your blood pressure readings. At-home blood pressure monitoring and lifestyle changes can help improve and maintain healthy blood pressure.

Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and ...

TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the ...

Bupropion SR: The starting dosage for treating depression is typically 150 mg once per day. After 3 days, your doctor may increase your dosage to 300 mg per day (150 mg taken twice, about 8 hours ...